Vyvanse and Testosterone drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Vyvanse (lisdexamfetamine dimesylate) and Testosterone (testosterone). Common drug interactions include hallucination among females and fatigue among males.

The phase IV clinical study analyzes what interactions people have when they take Vyvanse and Testosterone. It is created by eHealthMe based on reports of 38 people who take the same drugs from the FDA, and is updated regularly.

What is Vyvanse?

Vyvanse has active ingredients of lisdexamfetamine dimesylate. It is often used in attention deficit hyperactivity disorder. eHealthMe is studying from 35,872 Vyvanse users. Check the latest studies of Vyvanse.

What is Testosterone?

Testosterone has active ingredients of testosterone. It is often used in testosterone. eHealthMe is studying from 6,457 Testosterone users. Check the latest studies of Testosterone.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Sep, 03, 2026

38 people who take Vyvanse and Testosterone together, and have interactions are studied.

Vyvanse and Testosterone drug interactions.

What are the common drug interactions of Vyvanse and Testosterone, by gender? *:

female:

  1. Hallucination (an experience involving the perception of something not present)
  2. Headache (pain in head)
  3. Heart rate increased
  4. Idiopathic urticaria (allergic reactions, presence of hives with unknown cause)
  5. Influenza
  6. Infusion related reaction
  7. Kidney infection
  8. Myalgia (muscle pain)
  9. Nausea (feeling of having an urge to vomit)
  10. Nephrolithiasis (calculi in the kidneys)

male:

  1. Fatigue (feeling of tiredness)
  2. Pain
  3. Dysgeusia (disorder of the sense of taste)
  4. Headache (pain in head)
  5. Oropharyngeal pain
  6. Pollakiuria (abnormally frequent passage of relatively small quantities or urine)
  7. Sinus congestion (blockage of sinus)
  8. Bone density decreased
  9. Dysstasia (difficulty in standing)
  10. Musculoskeletal stiffness (stiffness of the body's muscles, joints, tendons, ligaments and nerves)

What are the common drug interactions of Vyvanse and Testosterone, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Cough
  2. Dysgeusia (disorder of the sense of taste)
  3. Fatigue (feeling of tiredness)
  4. Headache (pain in head)
  5. Insomnia (sleeplessness)
  6. Oropharyngeal pain
  7. Pain
  8. Pollakiuria (abnormally frequent passage of relatively small quantities or urine)
  9. Sinus congestion (blockage of sinus)
  10. Drug ineffective

30-39:

  1. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  2. Anxiety
  3. Blood testosterone decreased
  4. Bone density decreased
  5. Emotional distress
  6. Feeling hot
  7. Fracture
  8. Gastrointestinal motility disorder (abnormal intestinal contractions)
  9. Pain
  10. Serum serotonin decreased

40-49:

  1. Arthralgia (joint pain)
  2. Arthropathy
  3. Blood glucose decreased
  4. Chest discomfort
  5. Decreased appetite
  6. Drug ineffective
  7. Hallucination (an experience involving the perception of something not present)
  8. Heart rate increased
  9. Influenza
  10. Pain

50-59:

  1. Dry mouth
  2. Ear pain
  3. Escherichia sepsis (bacterial infection by escherichia coli)
  4. Groin pain
  5. Headache (pain in head)
  6. Idiopathic urticaria (allergic reactions, presence of hives with unknown cause)
  7. Infusion related reaction
  8. Kidney infection
  9. May-thurner syndrome (a rarely diagnosed condition in which patients develop iliofemoral deep venous thrombosis (dvt) due to an anatomical variant)
  10. Myalgia (muscle pain)

60+:

  1. Multiple sclerosis relapse (reoccurrence of a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath)
  2. Optic neuritis (optic nerve inflammation)

What are the existing conditions these people have? *

  1. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 14 people, 36.84%
  2. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 12 people, 31.58%
  3. Drowsiness: 11 people, 28.95%
  4. Depression: 5 people, 13.16%
  5. Pain: 4 people, 10.53%
  6. Hiv Infection: 3 people, 7.89%
  7. Thyroid Diseases: 3 people, 7.89%
  8. Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 3 people, 7.89%
  9. Insomnia (sleeplessness): 3 people, 7.89%
  10. Ulcerative Colitis (inflammatory bowel disease (ibd). it causes swelling, ulcerations, and loss of function of the large intestine): 3 people, 7.89%

* Approximation only. Some reports may have incomplete information.

Do you take Vyvanse and Testosterone?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Vyvanse and Testosterone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Vyvanse:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Testosterone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Vyvanse and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Testosterone and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on lisdexamfetamine dimesylate and testosterone (the active ingredients of Vyvanse and Testosterone, respectively), and Vyvanse and Testosterone (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: